Literature DB >> 28501259

Risk of Stroke/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-Analysis.

Yanting Zhang1, Ganfeng Luo1, Yuanwei Huang1, Qiuyan Yu2, Li Wang1, Ke Li3.   

Abstract

BACKGROUND: Accumulating evidence indicates that herpes zoster (HZ) may increase the risk of stroke/transient ischemic attack (TIA) or myocardial infarction (MI), but the results are inconsistent. We aim to explore the relationship between HZ and risk of stroke/TIA or MI and between herpes zoster ophthalmicus (HZO) and stroke.
METHODS: We estimated the relative risk (RR) and 95% confidence intervals (CIs) with the meta-analysis. Cochran's Q test and Higgins I2 statistic were used to check for heterogeneity.
RESULTS: HZ infection was significantly associated with increased risk of stroke/TIA (RR = 1.30, 95% CI: 1.17-1.46) or MI (RR = 1.18, 95% CI: 1.07-1.30). The risk of stroke after HZO was 1.91 (95% CI 1.32-2.76), higher than that after HZ. Subgroup analyses revealed increased risk of ischemic stroke after HZ infection but not hemorrhagic stroke. The risk of stroke was increased more at 1 month after HZ infection than at 1-3 months, with a gradual reduced risk with time. The risk of stroke after HZ infection was greater with age less than 40 years than 40-59 years and more than 60 years. Risk of stroke with HZ infection was greater without treatment than with treatment and was greater in Asia than Europe and America but did not differ by sex.
CONCLUSIONS: Our study indicated that HZ infection was associated with increased risk of stroke/TIA or MI, and HZO infection was the most marked risk factor for stroke. Further studies are needed to explore whether zoster vaccination could reduce the risk of stoke/TIA or MI.
Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke; herpes zoster; meta-analysis; myocardial infarction; risk

Mesh:

Substances:

Year:  2017        PMID: 28501259     DOI: 10.1016/j.jstrokecerebrovasdis.2017.04.013

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  12 in total

1.  Immunogenicity of Varicella Zoster Virus DNA Vaccines Encoding Glycoprotein E and Immediate Early Protein 63 in Mice.

Authors:  Jie Liu; Junyang Lin; Linjun Cai; Jie Sun; Xue Ding; Cenrong Wang; Yanchun Wu; Xiaoling Gao; Weiheng Su; Chunlai Jiang
Journal:  Viruses       Date:  2022-06-02       Impact factor: 5.818

2.  Effect of herpes zoster vaccine and antiviral treatment on risk of ischemic stroke.

Authors:  Quanhe Yang; Mary G George; Anping Chang; Xin Tong; Robert Merritt; Yuling Hong
Journal:  Neurology       Date:  2020-07-07       Impact factor: 9.910

Review 3.  Adult preventive vaccines with other synergistic lifestyle options: is it time to add these ancillary benefits to the overall AS management checklist?

Authors:  Mark A Moyad
Journal:  World J Urol       Date:  2021-05-07       Impact factor: 4.226

4.  Herpes Zoster Vaccine Live and Risk of Stroke Among Medicare Beneficiaries: A Population-Based Cohort Study.

Authors:  Quanhe Yang; Anping Chang; Xin Tong; Robert Merritt
Journal:  Stroke       Date:  2021-04-20       Impact factor: 10.170

5.  The Risk of Atrial Fibrillation after Herpes Zoster.

Authors:  Young Soo Lee
Journal:  J Korean Med Sci       Date:  2018-05-21       Impact factor: 2.153

6.  Association of herpesviruses and stroke: Systematic review and meta-analysis.

Authors:  Harriet J Forbes; Elizabeth Williamson; Laura Benjamin; Judith Breuer; Martin M Brown; Sinéad M Langan; Caroline Minassian; Liam Smeeth; Sara L Thomas; Charlotte Warren-Gash
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

Review 7.  A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile.

Authors:  Federica Brosio; Giulia Masetti; Giulio Matteo; Armando Stefanati; Giovanni Gabutti
Journal:  Infect Drug Resist       Date:  2018-09-05       Impact factor: 4.003

8.  The Unknown Health Burden of Herpes Zoster Hospitalizations: The Effect on Chronic Disease Course in Adult Patients ≥50 Years.

Authors:  Maria Francesca Piazza; Chiara Paganino; Daniela Amicizia; Cecilia Trucchi; Andrea Orsi; Matteo Astengo; Paolo Romairone; Simona Simonetti; Giancarlo Icardi; Filippo Ansaldi
Journal:  Vaccines (Basel)       Date:  2020-01-10

Review 9.  Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion.

Authors:  T Mark Doherty; Giuseppe Del Giudice; Stefania Maggi
Journal:  Ann Med       Date:  2019-04-26       Impact factor: 4.709

10.  Optimal gender-specific age for cost-effective vaccination with adjuvanted herpes zoster subunit vaccine in Chinese adults.

Authors:  Joyce H S You; Wai-Kit Ming; Owen Tak-Yin Tsang; Paul Kay-Sheung Chan
Journal:  PLoS One       Date:  2019-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.